Genomics surveillance programme for hepatitis C launched by UK Health Security Agency
The UK Health Security Agency (UKHSA) has launched a genomic surveillance programme for hepatitis C virus (HCV), “in a bid to monitor drug resistance, tackle harder to treat viral strains and detect outbreaks sooner”. In an announcement published on 12 March 2025, the UKHSA said the technology will allow “a better understanding of treatment outcomes […]
Publication Details
- Journal
- Pharmaceutical journal/The pharmaceutical journal
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1211/pj.2025.1.350498
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00